| Financial Year |
March 31 2023 |
| Monetary Funds |
511,459,671.57 |
| Held-for-trading Financial Assets |
110,000,000.00 |
| Notes Receivable |
1,948,700.00 |
| Accounts Receivable |
65,335,172.52 |
| Advances to Suppliers |
7,908,237.58 |
| Other Receivables |
6,601,172.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,854,167.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,286,776.95 |
| Total Current Assets |
881,730,399.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
112,559,227.00 |
| Investment Properties |
16,939,400.98 |
| Fixed Assetes |
188,213,590.48 |
| Under-construction Projects |
10,331,248.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,153,032.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,474,987.55 |
| Deferred Income Tax Assets |
5,909,573.73 |
| Other Non-Current Assets |
74,854,879.73 |
| Sub-Total of Non-Current Assets |
496,876,972.24 |
| Total Assets |
1,378,607,372.13 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
105,688,363.90 |
| Accounts Payable |
59,261,691.92 |
| Accounts Received In Advance |
106,594,875.04 |
| Employee Compensation Payable |
15,912,373.76 |
| Taxes Payable |
5,146,770.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,707,711.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,014,010.18 |
| Other Current Liabilities |
1,521,246.88 |
| Sub-Total of Current Liabilities |
425,330,187.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,319,952.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,329,614.53 |
| Total Liabilities |
451,659,801.66 |
| Paid-In Capital(Or Share Stock) |
459,352,513.00 |
| Capital Surplus |
20,497,268.67 |
| Surplus Reserve |
45,356,181.71 |
| LESS:Treasury Stock |
24,228,392.10 |
| Undistributed Profits |
404,711,073.00 |
| Minority Stockholder's Interest |
4,514,981.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
922,432,589.26 |
| Owner's Equity（Stockholder's Equity） |
926,947,570.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,378,607,372.13 |
